
New Botox Acquirer, Actavis, Experiences Leap in Revenue During 1st Quarter
Last year, Actavis acquired Allergan, Botox's manufacturer, in a $66 billion dollar deal. Actavis recently announced the first quarter financial... Read more »
Actavis Pharmaceutical Buys Botox Manufacturer Allergan In 66 Billion Dollar Deal
Pharmaceutical acquired Botox manufacturer Allergan in a $66 billion dollar deal, valued at $219 per share which was reported at... Read more »
Actavis Announces Plans to Adopt Allergan’s Name Post Botox Deal
According to CTV News, recent Botox acquirer, Actavis, plans on adopting the Allergan name. Actavis Pharmaceutical acquired the Botox manufacturer,... Read more »








